When the FDA recently convened a committee of advisers to assess a cardiac device made by Abbott, the agency didn’t disclose that most of them had received payments from the company or conducted research it had funded — information readily available in a federal database.
One member of the…
Click here to view original post
Click Here to Publish/Feature Your Company or Product News with Biotech Networks
Plexus Worldwide® Contributes 22,500 Meals to Salt Lake City Through Volunteer Initiative
Part of the company’s ongoing commitment to fighting hunger, the volunteer day included more than 50 local Brand Ambassadors and a $5,000 donation to Utah Food Bank SCOTTSDALE, Ariz., June 9, 2023 /PRNewswire/ — Plexus […]
Recursion raises $50M from Nvidia via PIPE
Recursion Pharmaceuticals raised $50 million from Nvidia via a PIPE that placed the AI biotech squarely into the investor fervor surrounding the tech company. Recursion said Wednesday morning it now plans to work with Nvidia […]
Thermo Fisher opens new $105M biologics manufacturing site outside of Nashville
While Nashville is known for producing the latest country music hits, Thermo Fisher is hoping its latest investment will have the area produce a lot more than just the latest ballads. The Massachusetts-based company has […]
